Src family kinases Fyn and Lyn are constitutively activated and mediate plasmacytoid dendritic cell responses

被引:29
作者
Dallari, S. [1 ]
Macal, M. [1 ]
Loureiro, M. E. [1 ]
Jo, Y. [1 ]
Swanson, L. [2 ]
Hesser, C. [1 ]
Ghosh, P. [2 ]
Zuniga, E. I. [1 ]
机构
[1] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, 9500 Gilman Dr Jolla, San Diego, CA 92093 USA
[2] Univ Calif San Diego, Dept Med & Cellular & Mol Med, 9500 Gilman Dr Jolla, San Diego, CA 92093 USA
关键词
I INTERFERON; B-CELL; PHOSPHOINOSITIDE; 3-KINASE; SPATIOTEMPORAL REGULATION; TYROSINE PHOSPHORYLATION; RECEPTOR; 9; INHIBITOR; INFECTION; ADAPTER; TRAFFICKING;
D O I
10.1038/ncomms14830
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Plasmacytoid dendritic cells (pDC) are type I interferon-producing cells with critical functions in a number of human illnesses; however, their molecular regulation is incompletely understood. Here we show the role of Src family kinases (SFK) in mouse and human pDCs. pDCs express Fyn and Lyn and their activating residues are phosphorylated both before and after Toll-like receptor (TLR) stimulation. Fyn or Lyn genetic ablation as well as treatment with SFK inhibitors ablate pDC (but not conventional DC) responses both in vitro and in vivo. Inhibition of SFK activity not only alters TLR-ligand localization and inhibits downstream signalling events, but, independent of ex-vivo TLR stimulation, also affects constitutive phosphorylation of BCAP, an adaptor protein bridging PI3K and TLR pathways. Our data identify Fyn and Lyn as important factors that promote pDC responses, describe the mechanisms involved and highlight a tonic SFK-mediated signalling that precedes pathogen encounter, raising the possibility that small molecules targeting SFKs could modulate pDC responses in human diseases.
引用
收藏
页数:16
相关论文
共 64 条
[1]   Type I interferon dependence of plasmacytoid dendritic cell activation and migration [J].
Asselin-Paturel, C ;
Brizard, G ;
Chemin, K ;
Boonstra, A ;
O'Garra, A ;
Vicari, A ;
Trinchieri, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (07) :1157-1167
[2]   Type I interferon in systemic lupus erythematosus and other autoimmune diseases [J].
Banchereau, Jacques ;
Pascual, Virginia .
IMMUNITY, 2006, 25 (03) :383-392
[3]  
Billadeau DD, 2002, J CLIN INVEST, V109, P161, DOI 10.1172/JCI14843
[4]   Intracellular Toll-like Receptors [J].
Blasius, Amanda L. ;
Beutler, Bruce .
IMMUNITY, 2010, 32 (03) :305-315
[5]   BDCA2/FcεRlγ complex signals through a novel BCR-like pathway in human plasmacytoid dendritic cells [J].
Cao, Wei ;
Zhang, Li ;
Rosen, David B. ;
Bover, Laura ;
Watanabe, Gokuran ;
Bao, Musheng ;
Lanier, Lewis L. ;
Liu, Yong-Jun .
PLOS BIOLOGY, 2007, 5 (10) :2190-2200
[6]   Signaling and ligand interaction of ILT7: receptor-mediated regulatory mechanisms for plasmacytoid dendritic cells [J].
Cao, Wei ;
Bover, Laura .
IMMUNOLOGICAL REVIEWS, 2010, 234 :163-176
[7]   Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3) K-mTOR-p70S6K pathway [J].
Cao, Weiping ;
Manicassamy, Santhakumar ;
Tang, Hua ;
Kasturi, Sudhir Pai ;
Pirani, Ali ;
Murthy, Niren ;
Pulendran, Bali .
NATURE IMMUNOLOGY, 2008, 9 (10) :1157-1164
[8]   Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation [J].
Chan, VWF ;
Meng, FY ;
Soriano, P ;
DeFranco, AL ;
Lowell, CA .
IMMUNITY, 1997, 7 (01) :69-81
[9]  
Chu T, 2015, J IMMUNOL, V194
[10]   RAPping production of type I interferon in pDCs through mTOR [J].
Costa-Mattioli, Mauro ;
Sonenberg, Nahum .
NATURE IMMUNOLOGY, 2008, 9 (10) :1097-1099